[NBIX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
14-Feb-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -58.65%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 788,100 451,240 161,626 15,000 19,769 0 2,919 154.12%
PBT 46,500 21,841 -142,542 -141,090 -88,929 -60,542 -46,090 -
Tax 9,500 730 17,103 -7,722 -6,271 -4,678 -4,243 -
NP 37,000 21,111 -142,542 -141,090 -88,929 -60,542 -46,090 -
Tax Rate -20.43% -3.34% - - - - - -
Total Cost 751,100 430,129 304,168 156,090 108,698 60,542 49,009 57.57%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 4.69 4.68 -88.19 -940.60 -449.84 0.00 -1,578.97 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 0.40 0.22 -1.62 -1.63 -1.05 -0.81 -0.69 -
EPS Diluted 0.39 0.22 -1.62 -1.63 -1.05 -0.81 -0.69 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.